Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Murielle Surquin

Status: Completed

Conditions: Covid19

Treatments: Other: Data collection from medical files

Study type: Observational

Funder types: Other

Identifiers

NCT04499300

CHUB-COVID-19-90+

Details and patient eligibility

About

SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called "Acute Respiratory Distress Syndrome". The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility.

This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.

Enrollment: 50 patients

Sex: All

Ages: 90+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be over 90 years of age on the date of admission to CHU Brugmann Hospital
• Have a SARS Cov2 infection proven by antigen or RT-PCR on smear and / or typical imaging regardless of the clinical manifestation
• Have been hospitalized at CHU Brugmann between 03/01/2020 and 05/10/2020

Exclusion criteria

None

Trial design

50 participants in 3 patient groups

Covid positive

Description:

Patients over 90 years old hospitalized within the CHU Brugmann between 03/01/2020 and 05/10/2020 with SARS Cov2 infection.

Treatment:

Other: Data collection from medical files

Sub-group: deceased patients

Description:

Patients over 90 years old hospitalized within the CHU Brugmann between 03/01/2020 and 05/10/2020 with SARS Cov2 infection, with death as outcome.

Treatment:

Other: Data collection from medical files

Sub-group: patients who survived

Description:

Patients over 90 years old hospitalized within the CHU Brugmann between 03/01/2020 and 05/10/2020 with SARS Cov2 infection, who survived the infection.

Treatment:

Other: Data collection from medical files